Hepatitis Test Solution/Diagnosis Market Worth $3.37 Billion by 2023

Tuesday, October 2, 2018 General News
Email Print This Page Comment bookmark
Font : A-A+

CHICAGO, October 2, 2018 /PRNewswire/ --

According to the new market research report "Hepatitis Test Solution/Diagnosis Market

 by Disease Type (Hepatitis B, HCV, HAV, HDV), Technology (ELISA, RDT, PCR, Transcription Mediated Amplification), End User (Hospitals, Diagnostic Laboratories, Blood Banks, Nursing Homes) - Global Forecast to 2023", published by
MarketsandMarkets™, the global Hepatitis Test Solution/Diagnosis Market is expected to reach USD 3.37 billion by 2023 from USD 2.66 billion in 2018, at a CAGR of 4.9% during the forecast period (2018-2023). 

     (Logo: https://mma.prnewswire.com/media/660509/MarketsandMarkets_Logo.jpg ) Don't miss out on business opportunities in Hepatitis Test Solution/Diagnosis Market.

Speak to Our Analyst and gain crucial industry insights that will help your business grow:

https://www.marketsandmarkets.com/speaktoanalyst.asp?id=139802887

Increasing number of blood transfusions & donations, high burden of hepatitis worldwide, benefits offered by point of care instruments & kits, and initiatives taken by government and non-government organizations are the major factors driving this market.

The ELISA segment is expected to hold the largest market share during the forecast period 

On the basis of technology, the Hepatitis Test Solution/Diagnosis Market is segmented into ELISA, rapid diagnostics test, PCR, INAAT, and other technologies. In 2018, the ELISA is expected to account for the largest market share, by technology. The wide acceptance of this test in clinical practices to diagnose hepatitis is the main factor driving this market.

Browse in-depth TOC on "Hepatitis Test Solution/Diagnosis Market"

69 - Tables  

29 - Figures  

112 - Pages  

View more detailed TOC @ https://www.marketsandmarkets.com/Market-Reports/hepatitis-test-solution-market-139802887.html

The hepatitis C segment is expected to grow at the highest rate in the next five years 

On the basis of disease type, the market is segmented into hepatitis B, hepatitis C, and other hepatitis disease. The hepatitis C segment is projected to grow at the highest CAGR during the forecast period. This growth is primarily attributed to the increasing incidence of HCV infections and limited vaccination coverage.

North America is expected to dominate the Hepatitis Test Solution/Diagnosis Market in 2018 

North America is expected to account for the largest share of the global Hepatitis Test Solution/Diagnosis Market in 2018. The large share of the North America region is primarily attributed to factors such as the rising adoption of advanced technologies, developed healthcare systems in the US and Canada, and the presence of a large number of leading national clinical laboratories.

The APAC region is expected to grow at the highest CAGR over the next five years. The growth of the Hepatitis Test Solution/Diagnosis Market in this region is driven by the modernization of healthcare infrastructure, high burden of hepatitis infections, increased healthcare spending by a larger population base, and the rising penetration of cutting-edge clinical laboratory technologies.

Request for Free Sample Report @  

https://www.marketsandmarkets.com/requestsample.asp?id=139802887    

The key players operating in this market include Abbott Laboratories (US), Roche (Switzerland), Bio-Rad (US), Siemens (Germany), DiaSorin (Italy), QIAGEN (Netherlands), bioMérieux (France), Danaher (US), and Grifols (Spain).

Browse Adjacent Markets @ Medical Devices Market Research Reports & Consulting

About MarketsandMarkets™  

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact: Mr. Shelly Singh MarketsandMarkets™ INC. 630 Dundee Road Suite 430 Northbrook, IL 60062 USA: +1-888-600-6441 Email: sales@marketsandmarkets.com

Research Insight: https://www.marketsandmarkets.com/ResearchInsight/hepatitis-test-solution-market.asp

Visit Our Website: https://www.marketsandmarkets.com

SOURCE MarketsandMarkets



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store